Prebeo LLC

Prebeo LLC is a medical technology company based in Baltimore, MD, dedicated to enhancing the evaluation of donor kidneys for more successful transplantations and ultimately saving lives. Their innovative Kidney Viability Assessment System (KVAS) utilizes optical coherence tomography and intelligent image analysis to provide a rapid and non-invasive evaluation of whole-kidney viability, supplementing the existing standard of care. With their cutting-edge technology, Prebeo aims to increase the number of donor kidneys deemed viable for transplant, significantly improving patient outcomes.

Supported by Early Charm, Prebeo is comprised of a team of scientists, engineers, and experts in the field. Co-founded by Dr. Yu Chen, the inventor of KVAS, Prebeo is at the forefront of utilizing OCT for novel biomedical applications. With leadership from Itso Ivanov in engineering, Ken Malone in business operations, and project management by Kelli Booth, Prebeo is committed to commercializing their technology and bringing it to market, revolutionizing the evaluation process for donor kidneys and making a significant impact in the field of transplantation.

Generated from the website